A new study demonstrates how changes in human genes can reduce SARS-CoV-2 infection and describes a wide array of genes that have not previously been considered as therapeutic targets for SARS-CoV-2.
CRISPR screen identifies genes, drug targets to protect against SARS-CoV-2 infection
